Business · 15/02/2024Updated: 10/17/2026 · 1 min read
FDA Issues Final Guidance on Charging for Investigational Drugs Under IND
Summary
The FDA has released a final guidance document addressing questions on charging for investigational drugs used in clinical trials or expanded access for treatment purposes, replacing a previous version from 2016.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →